Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized postmarketing trial of atropine and DIMS lenses for pediatric myopia control
2024-514651-15-00Phase 4Completed
- Sponsor
- Hospital Clínico San Carlos
- Start
- Feb 2022
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of atropine in myopia (2 arms), sponsored by Hospital Clínico San Carlos. Primary endpoints: Change in refractive error after cycloplegia and Proportion of patients with adverse events. Started Feb 2022; status: completed.
02
Drugs
atropine
03
Conditions
myopia
Beyond the preview
Go deeper on 2024-514651-15-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-514651-15-00.